Dexmedetomidine Hydrochloride Injection 100mcg/mL from Japan
This sterile injectable solution of dexmedetomidine hydrochloride is used for sedation in ICU patients during mechanical ventilation. It falls under HTS 3004.90.92.37 as a mixed product put up in measured doses containing dexmedetomidine salt for therapeutic use primarily affecting the central nervous system as a sedative. Supplied in 2mL single-dose vials for retail sale to hospitals.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Ensure FDA approval and NDC labeling for all imported sedatives; verify measured dose packaging
• Provide certificates of analysis confirming dexmedetomidine content and sterility to avoid customs holds
• Comply with DEA scheduling if applicable; watch for cold chain requirements during transit